Rasagiline in treatment of Parkinson’s disease

Rasagiline (N-propargyl-1 (R)-aminoindan) is a novel propargylamine, irreversible, selective monoamine oxidase inhibitor for treatment of Parkinson’s disease (PD), a progressive condition associated with degeneration of dopaminergic neurons in the substantia nigra. Rasagiline inhibits striatal dopam...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Nayak, Lakshmi, Henchcliffe, Claire
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2008
Teme:
Expert Opinion
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2515917/
https://ncbi.nlm.nih.gov/pubmed/18728823
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki